When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there’s not enough time to set off the cell’s alarm system.
Now, a Loyola University Chicago study has discovered the protein that helps the virus travel so fast. Researchers found that without this protein, the virus became stranded in the cytoplasm, where it was detected by the viral defense system. (The cytoplasm is the portion of the cell outside the nucleus.)
“By preventing its normal movement, we essentially turned HIV-1 into a sitting duck for cellular sensors,” said Edward M. Campbell, PhD, corresponding author of the study, published in the Proceedings of the National Academy of Sciences. Campbell is an associate professor in the Department of Microbiology and Immunology of Loyola University Chicago Stritch School of Medicine.
HIV-1 infects and kills immune system cells, including T cells and macrophages that were used in the study. This cripples the immune system, making the patient vulnerable to common bacteria, viruses and other pathogens that are usually harmless in people with healthy immune systems.
After HIV-1 enters a cell, it has to work its way through the cytoplasm to the nucleus. Once inside the nucleus, HIV-1 takes control of the cell and makes additional HIV-1 copies. But getting through the cytoplasm is not easy. Cytoplasm consists of fluid that is thick with proteins and structures such as mitochondria. “Something the size of a virus cannot just diffuse through the cytoplasm,” Campbell said. “It would be like trying to float to the bathroom in a very crowded bar. You need to have a plan.”
HIV-1 is able to get to the nucleus quickly via tubular tracks called microtubules. The virus attaches itself to a molecular motor called dynein, which moves down the microtubule like a train car on tracks.
Campbell and colleagues discovered the “ticket” HIV-1 needs to get on the train — a protein called bicaudal D2. HIV-1 binds to bicaudal D2, which recruits the dynein molecular motor. The dynein then transports HIV-1 towards the nucleus.
The finding raises the possibility of developing a drug that would prevent HIV-1 from binding to bicaudal D2, thus stranding the virus in the cytoplasm. This would not only prevent infection, but also give the cell time to turn on antiviral genes that would protect it and neighboring cells from infection.
Learn more: Study suggests a way to stop HIV in its tracks
The Latest on: HIV
- Illinois HIV Care Connect Encourages Social Media Conversations in "Speaking Up About HIV Stigma" Campaignon September 22, 2020 at 6:23 am
Illinois HIV Care Connect today launched its "Speaking Up About HIV Stigma" campaign. The stigmatization of persons living with HIV persists today, despite prevention and treatment breakthroughs that ...
- COVID-19 and HIV: So far, it seems the outcome is not what was fearedon September 22, 2020 at 5:29 am
Based on official figures—which may be somewhat under reported—COVID-19 has not been as devastating in South Africa as initially feared.
- HIV Diagnosis and Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027on September 22, 2020 at 4:21 am
The MarketWatch News Department was not involved in the creation of this content. Sep 22, 2020 (Market Insight Reports) -- The report on HIV Diagnosis and Treatment provides the clients with a ...
- The Military Is Waging War on HIV-Positive Soldierson September 22, 2020 at 2:00 am
Don’t ask, don’t tell is dead. But America’s armed services can still bar recruits and kick out those already serving.
- “Physical distance, not social distance”: supporting Jamaican women living with HIV during COVID-19on September 22, 2020 at 1:20 am
And there has been an increase in domestic violence. But for many women living with HIV in Jamaica, there are added layers of stress. According to the Jamaica Community of Positive Women (JCW+ ...
- HIV-era policy still limits gay men from giving blood during COVIDon September 21, 2020 at 3:58 pm
WHYY’s Zoe Read explains why a relic of the 1980s HIV epidemic still limits gay men from giving blood. She says Philly area politicians and LGBTQ advocates are pushing back. This is an FDA policy that ...
- Social Media Boosts Campaigns to Erase HIV Stigmaon September 20, 2020 at 5:01 pm
‘HIV Equal’ is just the latest online campaign to raise awareness and decrease stigma about HIV/AIDS. A mother who won’t drink from the same glass as her HIV-positive daughter. A restaurant owner who ...
- Woman with HIV denied water, medication in Texas jail before dying of neglect, family sayson September 19, 2020 at 10:00 am
LaSalle Corrections, the company that runs the for-profit jail, has been the subject of numerous lawsuits alleging medical neglect.
- Many practitioners are not prescribing HIV prevention medicationon September 19, 2020 at 7:39 am
Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study.
- How COVID-19 Is Hampering the Fight Against HIVon September 18, 2020 at 8:58 am
Clinics have stopped or limited HIV testing to focus on the new virus, and disruptions to the supply chain have led to shortages in life-saving HIV medication.
via Google News and Bing News